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1. cMAP precursors: NMR and mass spectra 
Mucic acid dimethyl ester.  
Figure S1: 1H NMR Spectrum of mucic acid dimethyl ester.
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N-boc protected mucic acid ethylenediamine.  
Figure S2: 1H NMR Spectrum of N-boc protected mucic acid ethylenediamine. 
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Figure S3: Electrospray Ionization (ESI) Mass Spectrum of N-boc protected mucic acid ethylenediamine. 
 
 
S5 
 
Mucic acid ethylenediamine. 
Structure S1: Mucic Acid Ethylenediamine. 
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Figure S4: 1H NMR Spectrum of Mucic Acid Ethylenediamine in D2O. 
 
  
S7 
 
Figure S5: 1H NMR Spectrum of Mucic Acid Ethylenediamine in DMSO.  
 
S8 
 
Figure S6: 13C NMR Spectrum of Mucic Acid Ethylenediamine in DMSO. 
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Table S1: 1H and 13C NMR peak assignments for Mucic Acid Ethylenediamine.  
 1H in D2O Chemical Shift 
(ppm) 
1H in DMSO Chemical 
Shift (ppm) 
13C in DMSO Chemical 
Shift (ppm) 
Methylene A 3.04 2.85 36.76 
Methylene B 3.45 Covered by H2O 39.25 
Methyne A 3.90 3.82 70.98 
Methyne B 4.32 4.15 71.39 
Hydroxyl A Not observed 4.55 N/A 
Hydroxyl B Not observed 5.30 N/A 
Amide and amines Not observed 7.83, 7.97 N/A 
Amide Carbonyl 
carbon 
N/A N/A 174.78 
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Figure S7: ESI Mass Spectrum of Mucic Acid Ethylenediamine.  
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2. Dimethyl Suberimidate (DMS) and DMS hydrolysis: NMR and mass spectra 
Dimethyl Suberimidate (DMS). 
Dimethyl suberimidate, the charged monomer with which mucic acid ethylenediamine was 
polymerized, was used as purchased from Thermo Scientific or Sigma-Aldrich. In order to assign peaks in 
the proton and carbon spectra of cMAP, NMR spectra of dimethyl suberimidate were acquired. Both 
proton and carbon NMR spectra of DMS were more complex than expected, suggesting that some 
hydrolysis was present in a freshly opened bottle. For example, the three protons of the methoxy peak 
for DMS have a chemical shift of 4.08 ppm, which completely shift to 3.55 ppm in a sample hydrolyzed in 
D2O. Similarly, the methylene peak adjacent to the methoxy (methylene A) has a chemical shift of 2.64 
ppm in DMS, which when hydrolyzed shifts more upfield to 2.25 ppm. 
Additionally there was the presence of dimethyl suberimidate containing one methoxy group which 
was completely hydrolyzed to a carboxylate group, as determined by both the ESI mass spectrum peak 
at m/z of 187.9 and the 1H-13C HMBC NMR spectrum. The methylene A peak in this case was present on 
1H NMR with a chemical shift of 2.01 ppm.  
 
Table S2: 1H NMR peak assignments for Dimethyl Suberimidate with varying degrees of hydrolysis.  
 Methoxy Methylene A Methylene B Methylene C 
Dimethyl suberimidate 4.08 2.64 1.60 1.30 
Dimethyl suberimidate hydrolyzed to the 
dimethyl ester 
3.55 2.25 1.45 1.20 
Dimethyl suberimidate hydrolyzed to 
carboxylate 
None 2.01 1.46 1.20 
 
Structure S2: Dimethyl Suberimidate. 
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Structure S3: Dimethyl Suberimidate hydrolyzed to the dimethyl ester.  
 
 
Structure S4: Dimethyl Suberimidate with one side hydrolyzed to the carboxylate. 
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Figure S8: 1H NMR Spectrum of Dimethyl Suberimidate. 
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Figure S9: 13C NMR Spectrum of Dimethyl Suberimidate.
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Figure S10: 1H-13C HMBC Spectrum of Dimethyl Suberimidate.
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Figure S11: 1H NMR Spectrum of Dimethyl Suberimidate hydrolyzed to the dimethyl ester. 
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Figure S12: 13C NMR Spectrum of Dimethyl Suberimidate hydrolyzed to the dimethyl ester.
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Figure S13: ESI Mass Spectrum of Dimethyl Suberimidate hydrolyzed to the dimethyl ester (m/z 202.9). Dimethyl suberimidate with one end 
hydrolyzed to the carboxylate is the peak with m/z 187.9. Dimethyl suberimidate with both ends hydrolyzed to the carboxylate is the peak 
with m/z 170.8.  
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3. cMAP: NMR spectra 
cationic Mucic Acid Polymer (cMAP). 
Structure S5: cMAP. 
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Figure S14: 1H NMR Spectrum of cMAP.  
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Table S3: 1H NMR peak assignments for cMAP. 
 
 
 Originating Monomer 1H in DMSO Chemical Shift (ppm) 
Amidine Mucic acid and dimethyl suberimidate 9.65 
Amidine Mucic acid and dimethyl suberimidate 9.28 
Amidine Mucic acid and dimethyl suberimidate 8.78 
Amide Mucic acid and dimethyl suberimidate 7.92 
Hydroxyl B Mucic acid 5.42 
Hydroxyl A Mucic acid 4.56 
Methyne B Mucic acid 4.18 
Methyne A Mucic acid 3.84 
Methoxy (end group) Dimethyl suberimidate 3.58 
Methylene B Mucic acid 3.40 
Methylene A Mucic acid 3.29 
Methylene A (end group) Mucic acid 2.87 
Methylene A Dimethyl suberimidate 2.42 
Methylene A (end group) Dimethyl suberimidate 2.30 
Methylene A (end group) Dimethyl suberimidate – hydrolyzed 
to carboxylate 
2.03 
Methylene B Dimethyl suberimidate 1.63 
Methylene B (end group) Dimethyl suberimidate 1.52 
Methylene C Dimethyl suberimidate 1.30 
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Figure S15: 13C NMR Spectrum of cMAP.
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Table S4: 13C NMR peak assignments for cMAP. 
 Originating Monomer 13C in DMSO Chemical Shift (ppm) 
Amide Carbonyl Mucic acid  174.29 
Methoxy Carbonyl (end group) Dimethyl suberimidate 173.47 
Amide Carbonyl (end group) Mucic acid 171.03 
Amidine Carbonyl Dimethyl suberimidate 167.79 
  166.82 
Methyne B Mucic acid 70.83 
Methyne A Mucic acid 70.61 
Methoxy (end group) Dimethyl suberimidate 51.31 
Methylene A Mucic acid 41.73 
Methylene B Mucic acid 36.37 
Methylene A Dimethyl suberimidate 32.15 
Methylene C Dimethyl suberimidate 27.48 
Methylene B Dimethyl suberimidate 26.31 
   
Methylene A (end group) Dimethyl suberimidate – 
hydrolyzed to carboxylate 
35.06 
Methylene A (end group) Dimethyl suberimidate 33.22 
Methylene B (end group) Dimethyl suberimidate 24.23 
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Figure S16: 1H-13C HSQC Spectrum of cMAP used to correlate proton and carbon chemical shifts. 
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Table S5: 1H-13C HSQC NMR peak assignments for cMAP. 
 Originating Monomer 1H Chemical 
Shift (ppm) 
13C Chemical 
Shift (ppm) 
Methyne B Mucic acid  4.18 70.85 
Methyne A Mucic acid 3.84 70.60 
Methoxy (end group) Dimethyl suberimidate 3.58 51.27 
Methylene A Mucic acid 3.29 41.69 
DMSO (Solvent) 2.50 39.68 
Methylene A (end group) Mucic acid 2.87 38.90 
Methylene B Mucic acid 3.39 36.34 
Methylene A Mucic acid 3.29 36.32 
Methylene A (end group) Dimethyl suberimidate 
(hydrolyzed to carboxylate) 2.04 35.06 
Methylene A (end group) Dimethyl suberimidate 2.30 33.22 
Methylene A Dimethyl suberimidate 2.42 32.16 
Methylene C Dimethyl suberimidate 1.30 27.48 
Methylene B Dimethyl suberimidate 1.63 26.25 
Methylene B (end group) Dimethyl suberimidate 1.52 24.23 
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Figure S17: 1H-1H COSY Spectrum of cMAP used to correlate protons to nearby protons more than one bond away. 
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Table S6: 1H-1H COSY NMR peak assignments for cMAP. 
Correlation 1H Chemical Shift 
(ppm) 
1H Chemical Shift 
(ppm) 
Methyne B Hydroxyl B 4.19 5.41 
Methyne B Methyne A 3.86 4.18 
Methyne A Hydroxyl A 3.86 4.55 
Methylene B (mucic acid) Amide 3.41 7.91 
Methylene B (mucic acid) Methylene A (end group, 
mucic acid) 3.38 2.87 
Methylene A (mucic acid) Amide 3.21 7.91 
Methylene A (end group, 
mucic acid) 
Methylene B (mucic acid) 2.88 3.39 
Methylene B (DMS) Methylene A (DMS) 1.64 2.43 
Methylene B (DMS) Methylene C (DMS) 1.64 1.30 
Methylene B (end group, 
DMS) 
Methylene A (end group, 
DMS) 1.53 2.31 
Methylene B (end group, 
DMS) 
Methylene A (end group, 
DMS hydrolyzed to 
carboxylate) 
1.49 2.05 
Methylene C (DMS) Methylene B (DMS) 1.31 1.63 
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Figure S18: 1H-13C HMBC Spectrum of cMAP used to correlate protons to carbons more than one bond away. 
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Table S7: 1H-13C HMBC NMR peak assignments for cMAP. 
Correlation 13C Chemical 
Shift (ppm) 
1H Chemical 
Shift (ppm) 
Carbonyl Carbon (DMS hydrolyzed 
to carboxylate) 
Methylene A (end group, DMS 
hydrolyzed to carboxylate) 174.53 2.04 
Amide Carbonyl (mucic acid) Methylene B (mucic acid) 174.36 3.38 
Amide Carbonyl (mucic acid) Hydroxyl B (mucic acid) 174.35 5.41 
Amide Carbonyl (mucic acid) Amide proton (mucic acid) 174.32 7.91 
Amide Carbonyl (mucic acid) Methylene A (mucic acid) 174.31 3.28 
Amide Carbonyl (mucic acid) Methyne B (mucic acid) 174.17 4.18 
Methyl ester carbonyl (DMS) Methoxy (DMS) 173.49 3.58 
Methyl ester carbonyl (DMS) Methylene A (end group, DMS) 173.48 2.30 
Methyl ester carbonyl (DMS) Methylene B (end group, DMS) 173.44 1.52 
Amide Carbonyl (end group) Methylene B (end group, mucic 
acid) 171.09 2.38 
Amidine Carbonyl Methylene A (DMS) 167.84 2.41 
Amidine Carbonyl Methylene B (DMS) 167.84 1.63 
Methyne B (mucic acid) Methyne A (mucic acid) 70.86 3.84 
Methyne B (mucic acid) Hydroxyl B (mucic acid) 70.83 5.41 
Methyne A (mucic acid) Methyne B (mucic acid) 70.71 4.18 
Methyne A (mucic acid) Hydroxyl A (mucic acid) 70.71 4.56 
Methylene A (mucic acid) Methylene B (mucic acid) 41.80 3.39 
Methylene A (mucic acid) Methylene A (mucic acid) 41.77 3.27 
DMSO DMSO 39.71 2.50 
Methylene B (mucic acid) Methylene A (end group, mucic 
acid) 36.50 2.87 
Methylene B (mucic acid) Amide Proton (mucic acid) 36.42 7.91 
Methylene B (mucic acid) Methylene A (mucic acid) 36.42 3.30 
Methylene A (end group, DMS) Methylene B (end group, DMS) 33.33 1.53 
Methylene A (DMS) Methylene B (DMS) 32.24 1.63 
Methylene A (DMS) Methylene C (DMS) 32.24 1.30 
Methylene B (end group, DMS) Methylene A (end group, DMS 
hydrolyzed to carboxylate) 28.26 2.05 
Methylene B (end group, DMS) Methylene A (end group, DMS) 28.02 2.30 
Methylene B (end group, DMS) Methylene B (end group, DMS) 28.00 1.52 
Methylene C (DMS) Methylene C (DMS) 27.61 1.29 
Methylene C (DMS) Methylene A (DMS) 27.61 2.41 
Methylene C (DMS) Methylene B (DMS) 27.57 1.63 
Methylene B (DMS) Methylene C (DMS) 26.41 1.29 
Methylene B (DMS) Methylene A (DMS) 26.34 2.42 
Methylene C (end group, DMS 
hydrolyzed to carboxylate) 
Methylene A (end group, DMS 
hydrolyzed to carboxylate) 25.00 2.04 
Methylene B (end group, DMS) Methylene A (end group, DMS) 24.33 2.30 
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Figure S19: 1H stacked DOSY Spectrum of cMAP showing that all the peaks on the cMAP polymer, including the small end group peaks, 
diffuse at the same rate. H2O and DMSO diffuse much faster as shown by their quick disappearance after the first spectrum (bottom). 
 Figure 
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Figure S20: 1H transformed DOSY Spectrum of cMAP showing that all the peaks on the cMAP polymer, including the small end group peaks, 
diffuse at the same rate. H2O and DMSO diffuse much faster. 
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4. cMAP: End group ratios 
Table S8: Ratios of amine: methoxy: carboxylate end groups in 8 batches of cMAP by comparing NMR 
integrations.  
Batch % amine % methoxy % carboxylate 
11 52.52 33.96 13.52 
12 38.45 54.15 7.40 
13 48.58 45.89 5.53 
14 47.07 45.71 7.22 
15 47.75 51.17 1.08 
16 55.58 37.14 7.28 
17 63.22 29.92 6.86 
18 38.76 39.50 21.75 
Average 48.99 ± 2.93  42.18 ± 2.99 6.22 ± 2.20 
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5. cMAP-PEG copolymer: NMR spectra 
Figure S21: 1H NMR of cMAP-PEG5k copolymer. The large resonance at 3.5 ppm corresponds to the PEG block. 
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Figure S22: 1H-13C HSQC spectrum of cMAP-PEG5k copolymer. 
 
 
S35 
 
Figure S23: 1H DOSY transformed spectrum of cMAP-PEG5k copolymer.
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Figure S24: 1H NMR of cMAP-PEG3.4k copolymer. 
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Figure S25: 13C NMR of cMAP-PEG3.4k copolymer. 
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Figure S26: 1H-13C HSQC spectrum of cMAP-PEG3.4k copolymer. 
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Figure S27: 1H DOSY transformed spectrum of cMAP-PEG3.4k copolymer. 
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5. cMAP-PEG copolymer fractionation yields 
A reaction was started with 50 mg of cMAP and 16.5 mg di-SPA-PEG3.4k. After stirring for 24 hours, the 
reaction was diluted in water and filtered through sequentially smaller molecular weight cutoff (MWCO) 
Amicon centrifugal spin filters. Some material loss does occur onto the filter membrane and during 
transfer steps, but the retained material on each of these filters after lyophilization to dryness is shown 
in the table below. A significant amount of high molecular weight cMAP-PEG3.4k copolymer is formed in 
the synthesis due to the presence of diamine end groups on cMAP.  
Table S9: Retained mass on each MWCO filter after fractionating crude cMAP-PEG3.4k copolymer. 
MWCO (kD) Mass (mg) Comment 
100 9.5 High molecular weight cMAP-PEG copolymer 
50 3.4 High molecular weight cMAP-PEG copolymer 
30 5 High molecular weight cMAP-PEG copolymer 
20 12.3 
 10 10.6 Pure cMAP-PEG-cMAP triblock 
3 13.2 Unreacted cMAP, excess PEG 
Total 54 
  
Similarly, a reaction was started with 50 mg of cMAP and 22.3 mg di-SVA-PEG5k. After stirring for 24 
hours, the reaction was diluted in water and filtered through sequentially smaller molecular weight 
cutoff (MWCO) Amicon centrifugal spin filters. Some material loss does occur onto the filter membrane 
and during transfer steps, but the retained material on each of these filters after lyophilization to 
dryness is shown in the table below. A significant amount of higher molecular weight cMAP-PEG5k 
copolymer is formed in this synthesis similar to the analogous reaction above.  
Table S10: Retained mass on each MWCO filter after fractionating crude cMAP-PEG5k copolymer. 
MWCO (kD) Mass (mg) Comment 
30 18.3 High molecular weight cMAP-PEG copolymer 
20 20.8 
 10 12 Pure cMAP-PEG-cMAP triblock + cMAP-PEG diblock 
Total 51.1 
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6. mPEG-cMAP-PEGm NMR spectra 
Figure S28: 1H NMR of mPEG5k-cMAP-PEG5km. The resonance at 3.5 ppm corresponds to the PEG blocks, and the resonance at 3.2 ppm is 
that of the methoxy end group on PEGm. 
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Figure S29: 1H-13C HSQC of mPEG5k-cMAP-PEG5km. 
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Figure S30: 1H DOSY transform of mPEG5k-cMAP-PEG5km. 
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Figure S31: 1H NMR of mPEG2k-cMAP-PEG2km. 
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Figure S32: 1H-13C HSQC of mPEG2k-cMAP-PEG2km. 
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Figure S33: 1H DOSY transform of mPEG2k-cMAP-PEG2km. 
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7. 5-nitrophenylboronic acid-PEGm NMR and MALDI spectra 
Figure S34: 1H NMR of 5-nPBA-PEGm. 
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Figure S35: 1H DOSY of 5-nPBA-PEGm showing that the 5-nitrophenylboronic acid group is attached to PEGm by the downfield protons’ 
persistence with PEG throughout the gradient sequence (compared to DMSO and H2O, which disappear after the first gradients applied). 
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Figure S36: 1H DOSY transform of 5-nPBA-PEGm showing that the downfield 5-nitrophenylboronic acid peaks diffuse at the same rate as the 
PEG peaks. 
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Figure S37: 11B NMR of 5-nPBA-PEGm. 11.26 ppm is the boronic acid peak. 19.54 ppm is boric acid (impurity). 
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Figure S38: MALDI mass spectrum of 5-nPBA-PEGm. 
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8. GPC: cMAP individual batch MW. 
Table S11: Gel Permeation Chromatography Analysis of cMAP Batches.  
Sample Mn Mw Mw/Mn (PDI) 
cMAP-DP11 5323 6068 1.14 
cMAP-DP12 5213 5839 1.12 
cMAP-DP13 5936 6365 1.07 
cMAP-DP14 5747 5940 1.03 
cMAP-DP15 5050 5568 1.10 
cMAP-DP16 6102 6357 1.04 
cMAP-DP17 7712 8235 1.07 
cMAP-DP18 7313 7524 1.03 
cMAP-DP19 8353 8984 1.08 
Values are reported as the average of 3 runs. 
 
9. GPC: other PEG length copolymer and triblock MW. 
Table S12: GPC Analysis of cMAP copolymers and triblocks (other than 5 kD PEG reported in main 
article text).  
Polymer dn/dc (mL/g) Mn (kD) Mw (kD) PDI (Mw/Mn) 
cMAP-PEG3.4k Copolymer 0.1660 128.30 289.25 2.27 
cMAP-PEG3.4k -cMAP 0.1660 used 
(not for pure 
triblock) 
12.89 14.20 1.10 
cMAP-PEG5k-cMAP 0.1660 used 
(not for pure 
triblock) 
24.17 26.84 1.11 
mPEG2k-cMAP-PEG2km 0.1654 9.75 9.81 1.01 
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10. siRNA encapsulation: Gel Retardation images 
Figure S39. cMAP gel retardation showing complete siRNA encapsulation at a charge ratio of 1+/-.  
 
 
Figure S40. cMAP-PEG3.4k copolymer gel retardation assay showing siRNA encapsulation at a charge 
ratio of 1+/- . 
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Figure S41. cMAP-PEG5k copolymer gel retardation assay showing siRNA encapsulation at a charge 
ratio of 2+/- . 
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11. siRNA encapsulation: RiboGreen comparing PEG lengths for copolymer and triblock 
Figure S42. cMAP-PEG copolymer RiboGreen assay showing siRNA encapsulation by a charge ratio of 
3+/- for 3.4k and 5k PEG blocks. 
 
Figure S43. mPEG-cMAP-PEGm triblock RiboGreen assay showing siRNA encapsulation by a charge 
ratio of 3+/- for 2k and 5k PEG blocks. 
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12. cMAP siRNA NP Salt Stability 
Figure S44. Without PEG, the cMAP-siRNA NP is unstable once in 1X PBS, but is stable for 2 days when 
5-nPBA-PEGm is used to stabilize the NP. 
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13. cMAP-PEG-cMAP pure triblock siRNA NP Salt Stability 
Table S13: NPs formed without extra 5-nPBA-PEGm using cMAP-PEG-cMAP triblock isolated from 
cMAP-PEG copolymer aggregates in 1X PBS, but is stable when at least one PEG per 2 diol groups is 
added to the formulation. The average sizes of the data presented in the following Figures are shown.  
Formulation  10 mM phosphate buffer PBS 
Avg. size (nm) Avg. size (nm) 
3.4k triblock, 1:1, 0 PEG 176.6 ± 1.0 aggregates 
3.4k triblock, 1:1, 0.5 PEG 100.1 ± 0.8 57.9 ± 0.9 
3.4k triblock, 1:1, 1 PEG 149.5 ± 1.6 56.5 ± 1.5 
3.4k triblock, 1:1, 2 PEG 85.9 ± 2.0 74.5 ± 3.4 
3.4k triblock, 3:1, 0 PEG 392.3 ± 5.0 aggregates 
3.4k triblock, 3:1, 0.5 PEG 42.8 ± 2.0 47.3 ± 2.0 
3.4k triblock, 3:1, 1 PEG 61.3 ± 2.3 55.7 ± 1.2 
3.4k triblock, 3:1, 2 PEG 115.9 ± 11.4 96.6 ± 1.6 
5k triblock, 1:1, 0 PEG 165.2 ± 4.7 aggregates 
5k triblock, 1:1, 0.5 PEG 141.3 ± 5.2 99.8 ± 3.8 
5k triblock, 1:1, 1 PEG 109.2 ± 3.6 97.5 ± 4.2 
5k triblock, 1:1, 2 PEG 179.1 ± 19.9 143.5 ± 5.4 
 
Figure S45. Without added 5-nPBA-PEGm, the cMAP-PEG3.4k-cMAP siRNA NP formulated at a 1+/- 
charge ratio aggregates once in 1X PBS, but is stable when at least one 5-nPBA-PEGm per two diol 
groups (0.5 PEG) on cMAP is added to the formulation. 
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Figure S46. Without added 5-nPBA-PEGm, the cMAP-PEG3.4k-cMAP siRNA NP formulated at a 3+/- 
charge ratio aggregates once in 1X PBS, but is stable when at least one 5-nPBA-PEGm per two diol 
groups (0.5 PEG) on cMAP is added to the formulation.
 
 
Figure S47. Without added 5-nPBA-PEGm, the cMAP-PEG5k-cMAP siRNA NP formulated at a 1+/- 
charge ratio aggregates once in 1X PBS, but is stable when at least one 5-nPBA-PEGm per two diol 
groups (0.5 PEG) on cMAP is added to the formulation.
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14. DLS Nanoparticle Size Distributions 
Figure S48: Lognormal size distribution by DLS for the cMAP + 5-nPBA-PEGm NP. 
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Figure S49: Lognormal size distribution by DLS for the CMAP-PEG copolymer NP. 
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Figure S50: Lognormal size distribution by DLS for the cMAP-PEG copolymer + 5-nPBA-PEGm NP. 
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Figure S51: Lognormal size distribution by DLS for the mPEG-cMAP-PEGm NP. 
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Figure S52: Lognormal size distribution by DLS for the mPEG-cMAP-PEGm + 5-nPBA-PEGm NP. 
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15. CryoTEM Nanoparticle Size Distributions and additional images 
 
Figure S53: Size distribution by CryoTEM for the cMAP + 5-nPBA-PEGm NP. 
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Figure S54: Additional CryoTEM images for the cMAP + 5-nPBA-PEGm NP. 
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Figure S55: Size distribution by CryoTEM for the cMAP-PEG copolymer NP. 
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Figure S56: Additional CryoTEM images for the cMAP-PEG copolymer NP. 
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Figure S57: Size distribution by CryoTEM for the cMAP-PEG copolymer + 5-nPBA-PEGm NP. 
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Figure S58: Additional CryoTEM images for the cMAP-PEG copolymer + 5-nPBA-PEGm NP. 
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Figure S59: Size distribution by CryoTEM for the mPEG-cMAP-PEGm NP.  
 
 
Figure S60: Additional CryoTEM images for the mPEG-cMAP-PEGm NP.  
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Figure S61: Size distribution by CryoTEM for the mPEG-cMAP-PEGm + 5-nPBA-PEGm NP.  
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Figure S62: Additional CryoTEM images for the mPEG-cMAP-PEGm + 5-nPBA-PEGm NP.  
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16. Phamacokinetics of mPEG-cMAP-PEGm NP in Balb/c vs. nude mice 
Figure S63: The circulation time of the mPEG-cMAP-PEGm siRNA NP is similar in Balb/c and nude mice. 
n=3 mice. 
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17. Gel images of mPEG-cMAP-PEGm NP in mouse serum 
Figure S64: This gel shows mPEG-cMAP-PEGm NPs with and without 5-nPBA-PEGm in mouse serum. 
The samples are run on a 0.5% agarose gel in Tris-Borate-EDTA buffer (pH 8) at 90V, and are detected 
by the Cy3 fluorophore labeled siRNA on a Typhoon gel scanner with laser excitation 532 nm, 
emission 580 nm. Lanes are labeled as follows. This shows that the NPs shift further down the gel due 
to protein adsorption but are intact in mouse serum. SDS dissociates the nanoparticle allowing the 
siRNA to run down the gel. 
1. mPEG-cMAP-PEGm NP  
2. mPEG-cMAP-PEGm NP in mouse serum 
3. mPEG-cMAP-PEGm NP in mouse serum + SDS 
4. mPEG-cMAP-PEGm + 5-nPBA-PEGm NP 
5. mPEG-cMAP-PEGm + 5-nPBA-PEGm NP in mouse serum 
6. mPEG-cMAP-PEGm + 5-nPBA-PEGm NP in mouse serum + SDS 
7. siRNA in mouse serum 
8. siRNA in mouse serum + SDS 
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Figure S65: A 0.5% agarose gel (made as described in Figure S64) is detected by ethidium bromide 
intercalating siRNA on a Biodocit gel imager. Lanes are labeled as follows. SDS dissociates the NP so 
the siRNA runs down the gel. This shows that the mPEG-cMAP-PEGm NP is intact in mouse serum, 
including in serum after 20 minutes of circulation post-injection. 
1. Mouse Serum 
2. Mouse Serum + SDS 
3. siRNA 
4. siRNA + SDS 
5. mPEG-cMAP-PEGm NP 
6. mPEG-cMAP-PEGm NP + SDS 
7. Serum collected at 20 min after mPEG-cMAP-PEGm NP injection 
8. Serum collected at 20 min after mPEG-cMAP-PEGm NP injection + SDS 
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Figure S66: This is the same gel as in Figure S60, but detected by the Cy3 fluorophore labeled siRNA on 
a Typhoon gel scanner with laser excitation 532 nm, emission 580 nm. Lanes are labeled as follows. 
SDS dissociates the NP. The bands detected by fluorescence line up well with the bands detected by 
ethidium bromide staining. This shows that the mPEG-cMAP-PEGm NP is intact in mouse serum, 
including in serum after 20 minutes of circulation after injection.  
1. Mouse Serum 
2. Mouse Serum + SDS 
3. siRNA 
4. siRNA + SDS 
5. mPEG-cMAP-PEGm NP 
6. mPEG-cMAP-PEGm NP + SDS 
7. Serum collected at 20 min after mPEG-cMAP-PEGm NP injection 
8. Serum collected at 20 min after mPEG-cMAP-PEGm NP injection + SDS 
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Figure S67: This gel is detected by the Cy3 fluorophore labeled siRNA on a Typhoon gel scanner with 
laser excitation 532 nm, emission 580 nm. Lanes are labeled as follows. SDS dissociates the NP. This 
shows that the mPEG-cMAP-PEGm NP is intact in mouse serum, including in serum after 20 minutes of 
circulation after injection.  
1. Mouse Serum 
2. mPEG-cMAP-PEGm NP 
3. mPEG-cMAP-PEGm NP in mouse serum 
4. mPEG-cMAP-PEGm NP in mouse serum + SDS 
5. Serum collected at 20 min after mPEG-cMAP-PEGm NP injection 
6. siRNA 
7. siRNA in mouse serum 
8. siRNA in mouse serum + SDS 
 
 
 
